Go Pro

Novartis (NVS) Short Interest Ratio & Short Volume

Novartis logo
$137.55 +0.07 (+0.05%)
Closing price 03:59 PM Eastern
Extended Trading
$137.70 +0.15 (+0.11%)
As of 05:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Novartis Short Interest Overview

As of August 31, 2026, Novartis (NVS) had a short interest of 5.63 million shares sold short, representing 0.29% of the public float. This marks a 12.65% increase in short interest since the prior report. The short interest ratio (days to cover) is 4.2, meaning it would take 4.2 days of the average trading volume of 2.00 million shares to cover all short positions.

Current Short Interest
5,625,158 shares
Previous Short Interest
4,993,689 shares
Change Vs. Previous Month
12.65%
Dollar Volume Sold Short
$856.26 million
Short Interest Ratio
4.2 Days to Cover
Last Record Date
August 31, 2026
Outstanding Shares
1,908,150,000 shares
Short Percent of Float
0.29%
Today's Trading Volume
2,419,753 shares
Average Trading Volume
2,003,562 shares
Today's Volume Vs. Average
121%
Short Selling Novartis?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Novartis and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

NVS Short Interest Over Time

NVS Days to Cover Over Time

NVS Percentage of Float Shorted Over Time

Novartis Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/20265,625,158 shares $856.26 million +12.7%0.3%4.22 $152.22
8/14/20264,993,689 shares $754.14 million -4.7%0.3%3.43 $151.02
7/31/20265,240,722 shares $818.47 million -8.3%0.3%2.69 $156.18
7/15/20265,713,789 shares $862.18 million +6.7%0.3%3.59 $150.89
6/30/20265,355,498 shares $839.72 million +2.1%0.3%1.95 $156.80
6/15/20265,246,790 shares $795.71 million +15.5%0.3%2.56 $151.66
5/29/20264,543,531 shares $682.54 million +1.5%0.2%3.67 $150.22
5/15/20264,475,369 shares $662.35 million -0.3%0.2%3.52 $148.00
4/30/20264,488,888 shares $664.35 million -22.4%0.2%2.95 $148.00
4/15/20265,785,672 shares $879.78 million -7.5%0.3%3.94 $152.06
3/31/20266,255,669 shares $955.48 million -17.0%0.3%3.41 $152.74
3/13/20267,533,454 shares $1.16 billion +10.0%0.4%2.45 $153.46
2/27/20266,848,820 shares $1.15 billion -8.5%0.3%2.44 $168.61
2/13/20267,488,605 shares $1.22 billion +46.4%0.4%2.47 $163.09
1/30/20265,116,628 shares $760.87 million -9.5%0.2%2.79 $148.71
1/15/20265,650,772 shares $809.09 million -5.7%0.3%3.38 $143.18
12/31/20255,989,213 shares $825.73 million +10.4%0.3%4.73 $137.87
12/15/20255,422,912 shares $733.24 million +9.0%0.3%3.07 $135.21
11/28/20254,976,663 shares $648.09 million -8.3%0.2%2.69 $130.23
11/14/20255,426,777 shares $711.78 million -5.6%0.3%3.74 $131.16
10/31/20255,749,914 shares $712.54 million +32.2%0.3%3.09 $123.92
10/15/20254,350,000 shares $565.39 million No Change0.2%3.1 $129.98
9/30/20254,350,000 shares $557.58 million +1.9%0.2%2.8 $128.18
9/15/20254,270,000 shares $526.36 million -2.5%0.2%2.9 $123.27
8/31/20254,380,000 shares $553.65 million +10.3%0.2%2.9 $126.41
8/15/20253,970,000 shares $493.07 million -9.4%0.2%2.6 $124.20
7/31/20254,380,000 shares $497.66 million +3.1%0.2%2.7 $113.62
7/15/20254,250,000 shares $508.57 million +4.7%0.2%2.5 $119.66
6/30/20254,060,000 shares $491.58 million +4.9%0.2%2.4 $121.08
6/15/20253,870,000 shares $461.85 million +15.9%0.2%2.1 $119.34
5/31/20253,340,000 shares $386.34 million -0.3%0.2%1.6 $115.67
5/15/20253,350,000 shares $363.04 million -27.2%0.2%1.4 $108.37
4/30/20254,600,000 shares $521.00 million +2.0%0.2%1.9 $113.26
4/15/20254,510,000 shares $495.38 million +39.6%0.2%1.8 $109.84
3/31/20253,230,000 shares $360.09 million -19.7%0.2%1.4 $111.48
3/15/20254,020,000 shares $438.77 million -20.2%0.2%2 $109.15
2/28/20255,040,000 shares $549.64 million +26.3%0.3%2.8 $109.06
2/15/20253,990,000 shares $420.66 million -2.2%0.2%2.4 $105.43
1/31/20254,080,000 shares $426.98 million -7.7%0.2%2.8 $104.65
1/15/20254,420,000 shares $437.80 million +9.1%0.2%3.4 $99.05
Trump and Bernie agree on this (Ad)

Donald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.tc pixel

Watch Porter Stansberry's full investment broadcast now
12/31/20244,050,000 shares $394.11 million -3.8%0.2%3.5 $97.31
12/15/20244,210,000 shares $414.10 million -6.2%0.2%3.7 $98.36
11/30/20244,490,000 shares $474.91 million -6.3%0.2%4 $105.77
11/15/20244,790,000 shares $493.66 million +0.6%0.2%4.2 $103.06
10/31/20244,760,000 shares $515.89 million -0.6%0.2%4.5 $108.38
10/15/20244,790,000 shares $556.79 million -16.0%0.2%4.7 $116.24
9/30/20245,700,000 shares $655.67 million +7.1%0.3%4.9 $115.03
9/15/20245,320,000 shares $615.31 million -6.7%0.3%4.4 $115.66
8/31/20245,700,000 shares $689.07 million -2.9%0.3%4.5 $120.89
8/15/20245,870,000 shares $665.25 million +4.6%0.3%4.5 $113.33
7/31/20245,610,000 shares $625.46 million -10.0%0.3%4.2 $111.49
7/15/20246,230,000 shares $687.36 million -0.2%0.3%4.2 $110.33
6/30/20246,240,000 shares $664.31 million -0.6%0.3%4.3 $106.46
6/15/20246,280,000 shares $663.92 million +60.2%0.3%4.1 $105.72
5/31/20243,920,000 shares $404.27 million -23.6%0.2%2.6 $103.13
5/15/20245,130,000 shares $529.52 million +21.6%0.3%3.3 $103.22
4/30/20244,220,000 shares $409.89 million +10.8%0.2%2.7 $97.13
4/15/20243,810,000 shares $359.66 million -9.5%0.2%2.4 $94.40
3/31/20244,210,000 shares $407.23 million +1.5%0.2%2.9 $96.73
3/15/20244,150,000 shares $403.71 million -8.4%0.2%3 $97.28
2/29/20244,530,000 shares $457.17 million +10.0%0.2%3.1 $100.92
2/15/20244,120,000 shares $410.39 million +5.9%0.2%2.8 $99.61
1/31/20243,890,000 shares $402.58 million -10.4%0.2%2.7 $103.49
1/15/20244,340,000 shares $466.33 million +15.1%0.2%2.8 $107.45
12/31/20233,770,000 shares $380.66 million +5.9%0.2%2.3 $100.97
12/15/20233,560,000 shares $346.74 million +4.7%0.2%2.2 $97.40
11/30/20233,400,000 shares $332.83 million -11.5%0.2%2.2 $97.89
11/15/20233,840,000 shares $360.19 million +5.2%0.2%2.6 $93.80
10/31/20233,650,000 shares $341.57 million +13.4%0.2%2.7 $93.58
10/15/20233,220,000 shares $313.11 million -19.1%0.2%2.6 $97.24
9/30/20233,980,000 shares $405.40 million +2.1%0.2%3.2 $101.86
9/15/20233,900,000 shares $400.26 million -2.5%0.2%3 $102.63
8/31/20234,000,000 shares $401.92 million +2.8%0.2%2.8 $100.48
8/15/20233,890,000 shares $399.08 million +2.6%0.2%2.2 $102.59
7/31/20233,790,000 shares $397.57 million +1.3%0.2%2 $104.90
7/15/20233,740,000 shares $369.62 million -2.6%0.2%1.9 $98.83
6/30/20233,840,000 shares $387.42 million -7.0%0.2%1.9 $100.89
6/15/20234,130,000 shares $418.70 million -5.7%0.2%2 $101.38
5/31/20234,380,000 shares $421.53 million +2.3%0.2%1.9 $96.24
5/15/20234,280,000 shares $441.35 million -10.5%0.2%2.1 $103.12
4/30/20234,780,000 shares $490.28 million -13.1%0.2%2.3 $102.57
4/15/20235,500,000 shares $538.34 million -13.1%0.3%2.5 $97.88
3/31/20236,330,000 shares $582.36 million No Change0.3%2.8 $92.00
3/15/20236,330,000 shares $519.69 million -4.1%0.3%3.1 $82.10
2/28/20236,600,000 shares $555.19 million +2.5%0.3%3.4 $84.12
2/15/20236,440,000 shares $561.44 million +16.9%0.3%3.3 $87.18
1/31/20235,510,000 shares $499.32 million +3.6%0.3%2.7 $90.62
1/15/20235,320,000 shares $484.44 million +11.1%0.2%2.6 $91.06
12/30/20224,790,000 shares $434.55 million -10.6%0.2%2.4 $90.72
12/15/20225,360,000 shares $487.17 million +1.3%0.2%2.5 $90.89
Trump and Bernie agree on this (Ad)

Donald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.tc pixel

Watch Porter Stansberry's full investment broadcast now
11/30/20225,290,000 shares $473.77 million +0.6%0.2%2.4 $89.56
11/15/20225,260,000 shares $440.95 million -14.1%0.2%2.1 $83.83
10/31/20226,120,000 shares $496.52 million +0.7%0.3%2.6 $81.13
10/15/20226,080,000 shares $459.47 million +6.3%0.3%2.6 $75.57
9/30/20225,720,000 shares $434.78 million +2.3%0.3%2.4 $76.01
9/15/20225,590,000 shares $451.34 million -1.2%0.3%2.6 $80.74
8/31/20225,660,000 shares $455.74 million -10.7%0.3%2.6 $80.52
8/15/20226,340,000 shares $541.31 million +4.1%0.3%3.2 $85.38
7/31/20226,090,000 shares $522.70 million +1.2%0.3%2.7 $85.83
7/15/20226,020,000 shares $509.53 million +0.5%N/A2.6 $84.64
6/30/20225,990,000 shares $506.33 million -4.0%N/A2.5 $84.53
6/15/20226,240,000 shares $507.69 million +4.5%N/A2.6 $81.36
5/31/20225,970,000 shares $542.91 million -15.7%0.3%2.4 $90.94
5/15/20227,080,000 shares $607.61 million +10.8%0.3%2.7 $85.82
4/30/20226,390,000 shares $562.51 million -2.6%0.3%2.4 $88.03
4/15/20226,560,000 shares $606.93 million +6.7%0.3%2.4 $92.52
3/31/20226,150,000 shares $539.66 million -2.2%0.3%2.3 $87.75
3/15/20226,290,000 shares $532.95 million +10.7%0.3%2.3 $84.73
2/28/20225,680,000 shares $496.77 million +4.0%0.3%2 $87.46
2/15/20225,460,000 shares $471.85 million -25.9%0.2%2 $86.42
1/31/20227,370,000 shares $640.53 million +12.7%0.3%2.9 $86.91
1/15/20226,540,000 shares $592.20 million -11.4%0.3%2.6 $90.55
12/31/20217,380,000 shares $645.53 million +39.0%0.3%3.1 $87.47
12/15/20215,310,000 shares $432.87 million -20.5%0.2%2.2 $81.52
11/30/20216,680,000 shares $532.40 million +8.6%0.3%3.1 $79.70
11/15/20216,150,000 shares $506.02 million +3.7%0.3%2.9 $82.28
10/29/20215,930,000 shares $490.77 million +8.2%0.3%2.8 $82.76
10/15/20215,480,000 shares $456.65 million -3.0%0.3%2.8 $83.33
9/30/20215,650,000 shares $462.06 million +0.9%0.3%2.9 $81.78
9/15/20215,600,000 shares $476.45 million +16.7%0.3%3.1 $85.08

NVS Short Interest - Frequently Asked Questions

Short interest is the volume of Novartis shares that have been sold short but have not yet been closed out or covered. As of August 14th, investors have sold 4,993,689 shares of NVS short. 0.26% of Novartis' shares are currently sold short. Learn More on Novartis' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NVS shares currently have a short interest ratio of 3.4. Learn More on Novartis's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.26% of Novartis' floating shares are currently sold short.

Novartis saw a decrease in short interest in August. As of August 14th, there was short interest totaling 4,993,689 shares, a decrease of 4.7% from the previous total of 5,240,722 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.26% of Novartis' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceuticals" compare to Novartis: Eli Lilly and Company (0.70%), Johnson & Johnson (0.90%), Merck & Co., Inc. (0.99%), Astrazeneca Plc (0.12%), Novo Nordisk A/S (0.76%), Pfizer Inc. (2.64%), Bristol Myers Squibb Company (2.25%), Sanofi (0.30%), GSK PLC Sponsored ADR (0.81%), Takeda Pharmaceutical Co. (0.09%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($71.57 billion), Invesco QQQ ($46.97 billion), iShares Russell 2000 ETF ($24.02 billion), Nebius Group N.V. ($15.37 billion), Sandisk Corporation ($12.60 billion), SPDR S&P Biotech ETF ($12.14 billion), Western Digital Corporation ($10.32 billion), iShares 20+ Year Treasury Bond ETF ($8.38 billion), VanEck Semiconductor ETF ($7.62 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.07 billion). View all of the most shorted stocks.

Short selling NVS is an investing strategy that aims to generate trading profit from Novartis as its price is falling. NVS shares are trading up $1.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Novartis occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NVS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVS, twice per month. The most recent reporting period available is August, 14 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like NVS:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for NYSE:NVS is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 9/10/2026. FINRA publishes updated short interest twice a month.
From Our Partners